Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized trial of trastuzumab versus lapatinib monotherapy in HER2-positive metastatic breast cancer
2008-001916-18Phase 2Active
- Sponsor
- Azienda Ospedaliera Ordine Mauriziano
- Start
- Mar 2009
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in breast cancer comparing Trastuzumab monotherapy with Lapatinib monotherapy (2 arms). Primary endpoint: Tumor response rate. Started Mar 2009; status: active.
02
Drugs
trastuzumablapatinib
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2008-001916-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001916-18.